Researchers from the University of Melbourne and Austin Health have created an innovative blood test that can help patients with coronary artery disease to predict their risk of heart attack and death.
The test can detect ACE2, an enzyme that is an essential regulator of heart function.
Results from the test were presented by the researchers at The Austin health and University of Melbourne. It stated that patients with coronary artery disease who had high ACE2 levels circulating in their blood were greatly at risk of suffering from a heart attack within a period of 10 years.
This study has the possibility to change clinical practice for coronary artery disease which continues to be the leading cause of death in Australia, says Professor Louise Burrell.
“We have come a long way in treating coronary artery disease, but certain patients continue to be at high risk of dying,”
“This new blood test helped identify such patients who may derive benefit from more aggressive treatment.”
The researchers enlisted 79 patients with coronary artery disease. During the 10-year follow up period, 46% of patients experienced heart attacks, heart failure and death.
Based from the findings published in journal PLOS ONE, these incidents happened in patients with the highest level of ACE2.
“If this were the case, the ACE2 blood test could be offered to all patients with coronary artery disease as part of their risk assessment,” Prof Burrell said.